Drugs / RG7185
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01209221 | Sep 2010 → Oct 2011 | — | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RG7185 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3544941 ↗ |
| Known as | RO5271983 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01209221 ↗ |
| Action | Inhibit | “G protein-coupled receptor 44 antagonist” CHEMBL3544941 ↗ |
| Route | Oral | “single oral dose of RO5271983 or placebo” NCT01209221 ↗ |
| Target | PTGDR2 | “G protein-coupled receptor 44 antagonist” CHEMBL3544941 ↗ |